melt-300
Generic: ketamine + midazolam
melt-300: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| HARROW, INC. (IMMY) | Phase 3 |
FDA Decisions
Approval(IMMY)
Frequently asked questions
Who is developing melt-300?
melt-300 is being developed by HARROW, INC..
What is melt-300's latest FDA decision?
The most recent tracked FDA decision for melt-300 is Approval, dated September 26, 2025.
Get deeper analysis on melt-300
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis